MedPath

Pseudodrynaria Coronana (Wall) Ching

Phase 1
Completed
Conditions
Osteoporosis
Registration Number
NCT00155675
Lead Sponsor
National Taiwan University Hospital
Brief Summary

The Study to evaluate the clinical effect of "Gusuibu" lasts for 3 years. It aims to evaluate its effect on bone density of postmenopausal osteoporosis. Besides, its effects on the liver, kidney and the hematological influence will be evaluated, too.

Detailed Description

Research of the this traditional chinese medicine clinucal, Gusuibu, curative effect is plan three years time. The entire studyaims to evaluated the effect of the traditional chinese medicine on postmenpausal osteoporosis as well as the possible side effects on the experimental animal and the human body. All subjects were postmenopausal woman with established osteoporosis.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • postmenopausal osteoporosis
Exclusion Criteria
  • Insulin dependent diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
one year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Taiwan University Medical Center

🇨🇳

Taipei, 7, Chung-Shan S. Road, Taiwan

© Copyright 2025. All Rights Reserved by MedPath